𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CNTO 1275 (anti-IL-12/23p40) treatment of psoriasis: Phase III trial results

Book ID
116583942
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
48 KB
Volume
58
Category
Article
ISSN
1097-6787

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Ustekinumab, an anti-IL-12/23 p40 monocl
Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials
✍ Kavanaugh, Arthur (author);Ritchlin, Christopher (author);Rahman, Proton (author πŸ“‚ Article πŸ“… 2014 πŸ› BMJ Publishing Group 🌐 English βš– 984 KB
Ustekinumab, an anti-IL-12/23 p40 monocl
Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials
✍ Kavanaugh, Arthur (author);Ritchlin, Christopher (author);Rahman, Proton (author πŸ“‚ Article πŸ“… 2014 πŸ› BMJ Publishing Group 🌐 English βš– 984 KB